Autism, Alzheimer’s, multiple sclerosis and other central nervous system disorders are very visible in today’s society. Because of the nature of these disorders, we are committed to their prevention and treatment through both biopharmaceutical and medical device and diagnostic development.

Chiltern has a team of neurologists and other medical professionals who specialize in central nervous system diseases — adding support and value to your project with their expertise and leadership. Working as a cross-functional group, the team collaborates with you to provide neurological advice from medical, operational, regulatory and cost-efficiency perspectives. The relationships they foster with major neurological thought leaders and research centers around the world allow them to provide deeper insights and strategic guidance, leading to better patient experiences, improved clinical outcomes and expedited regulatory approvals.

Chiltern has deep roots in in vitro diagnostic (IVD) clinical research. Our diagnostic experience includes genetic sequencing and biomarker development; IVD development including companion diagnostics; radiological and imaging modalities development; and mobile medical applications (MMA) and MMA-diagnostic medical device research.

Over the last five years, Chiltern has conducted 178 neuroscience studies.



Neuroscience Bio and Med Device

Indication Breakdown
(Hover for details)
Studies By Phase
(Hover for details)

Let us help you reach your program’s goals with a comprehensive range of collaborative services: